Looking to expand your partner network with the latest in the field of Psychiatric disorders? Consider joining Inpart's global network for free.
In Depth 27 Jun 2025
Psychedelics sans side effects: neuroplastogens gain ground
The past year has seen several developments in the neuroplastogens field, including Elkedonia’s seed funding to address neuropsychiatric disorders.